These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
488 related articles for article (PubMed ID: 18456464)
1. Diffuse cutaneous dissemination of visceral leishmaniasis during human immunodeficiency virus (HIV) infection, despite negligible immunodeficiency: repeated failure of liposomal amphotericin B administration, followed by successful long-term pentamidine and paromomycin administration. Manfredi R; Marinacci G; Calza L; Passarini B Int J Antimicrob Agents; 2008 Jun; 31(6):590-2. PubMed ID: 18456464 [No Abstract] [Full Text] [Related]
2. Treatment of visceral leishmaniasis unresponsive to pentamidine with amphotericin B. Mishra M J Assoc Physicians India; 1995 Apr; 43(4):306. PubMed ID: 8713286 [No Abstract] [Full Text] [Related]
3. U.S Food and Drug Administration approval of AmBisome (liposomal amphotericin B) for treatment of visceral leishmaniasis. Berman JD Clin Infect Dis; 1999 Jan; 28(1):49-51. PubMed ID: 10391695 [No Abstract] [Full Text] [Related]
4. Liposomal amphotericin B for the treatment of visceral leishmaniasis. Bern C; Adler-Moore J; Berenguer J; Boelaert M; den Boer M; Davidson RN; Figueras C; Gradoni L; Kafetzis DA; Ritmeijer K; Rosenthal E; Royce C; Russo R; Sundar S; Alvar J Clin Infect Dis; 2006 Oct; 43(7):917-24. PubMed ID: 16941377 [TBL] [Abstract][Full Text] [Related]
5. U.S. Food and Drug Administration approval of AmBisome (liposomal amphotericin B) for treatment of visceral leishmaniasis. Meyerhoff A Clin Infect Dis; 1999 Jan; 28(1):42-8; discussion 49-51. PubMed ID: 10028069 [TBL] [Abstract][Full Text] [Related]
6. Successful treatment of visceral leishmaniasis with liposomal amphotericin B. Lagler H; Matt U; Sillaber C; Winkler S; Graninger W Acta Biomed; 2006; 77 Suppl 2():22-5. PubMed ID: 16918063 [TBL] [Abstract][Full Text] [Related]
7. Injectable paromomycin for Visceral leishmaniasis in India. Sundar S; Jha TK; Thakur CP; Sinha PK; Bhattacharya SK N Engl J Med; 2007 Jun; 356(25):2571-81. PubMed ID: 17582067 [TBL] [Abstract][Full Text] [Related]
8. Challenges in the management of visceral leishmaniasis. Sundar S; Kumar A Indian Pediatr; 2005 Jun; 42(6):523-6. PubMed ID: 15995268 [No Abstract] [Full Text] [Related]
9. Treatment of visceral leishmaniasis with a 10 day course of L-ampB-LRC (Bombay), a liposomal amphotericin B. Bodhe PV; Pathare AV; Kshirsagar NA; Pandya SK J Assoc Physicians India; 1996 Mar; 44(3):222. PubMed ID: 9251329 [No Abstract] [Full Text] [Related]
10. Treatment of visceral leishmaniasis with intravenous pentamidine and oral fluconazole in an HIV-positive patient with chronic renal failure--a case report and brief review of the literature. Rybniker J; Goede V; Mertens J; Ortmann M; Kulas W; Kochanek M; Benzing T; Arribas JR; Fätkenheuer G Int J Infect Dis; 2010 Jun; 14(6):e522-5. PubMed ID: 19726213 [TBL] [Abstract][Full Text] [Related]
11. Successful treatment of post-kala-azar dermal leishmaniasis (PKDL) in a HIV infected patient with multiple relapsing leishmaniasis from Western Europe. Rihl M; Stoll M; Ulbricht K; Bange FC; Schmidt RE J Infect; 2006 Jul; 53(1):e25-7. PubMed ID: 16274744 [TBL] [Abstract][Full Text] [Related]
12. Liposomal amphotericin B for visceral leishmaniasis in human immunodeficiency virus-coinfected patients: 2-year treatment outcomes in Bihar, India. Sinha PK; van Griensven J; Pandey K; Kumar N; Verma N; Mahajan R; Kumar P; Kumar R; Das P; Mitra G; Flevaud L; Ferreyra C; Remartinez D; Pece M; Palma PP Clin Infect Dis; 2011 Oct; 53(7):e91-8. PubMed ID: 21890763 [TBL] [Abstract][Full Text] [Related]
13. Visceral leishmaniasis and Coombs' positive hemolytic anemia: a rare association in an infant treated with liposomal amphotericin B. Dilber E; Erduran E; Işik Y Turk J Pediatr; 2002; 44(4):354-6. PubMed ID: 12458816 [TBL] [Abstract][Full Text] [Related]
14. Visceral leishmaniasis in renal transplant recipients: successful treatment with liposomal amphotericin B (AmBisome). Boletis JN; Pefanis A; Stathakis C; Helioti H; Kostakis A; Giamarellou H Clin Infect Dis; 1999 Jun; 28(6):1308-9. PubMed ID: 10451172 [TBL] [Abstract][Full Text] [Related]